118 related articles for article (PubMed ID: 31084510)
1. High serum caspase-3 levels in hepatocellular carcinoma prior to liver transplantation and high mortality risk during the first year after liver transplantation.
Lorente L; Rodriguez ST; Sanz P; González-Rivero AF; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Portero J; Barrera MA
Expert Rev Mol Diagn; 2019 Jul; 19(7):635-640. PubMed ID: 31084510
[No Abstract] [Full Text] [Related]
2. Low Serum Melatonin Levels Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma are Associated with Lower Survival after Liver Transplantation.
Lorente L; Rodriguez ST; Sanz P; Abreu-González P; González-Rivero AF; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Portero J; Barrera MA
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959735
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Serum Caspase-Cleaved Cytokeratin-18 Levels before Liver Transplantation for One-Year Survival of Patients with Hepatocellular Carcinoma.
Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Barrera MA
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618033
[TBL] [Abstract][Full Text] [Related]
4. Serum total antioxidant capacity prior to liver transplantation for hepatocellular carcinoma is associated with 1-year liver transplantation survival.
Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Abreu-González P; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Cerro P; Barrera MA
J Int Med Res; 2018 Jul; 46(7):2641-2649. PubMed ID: 29911482
[TBL] [Abstract][Full Text] [Related]
5. High serum soluble CD40L levels previously to liver transplantation in patients with hepatocellular carcinoma are associated with mortality at one year.
Lorente L; Rodriguez ST; Sanz P; Pérez-Cejas A; Padilla J; Díaz D; González A; Martín MM; Jiménez A; Barrera MA
J Crit Care; 2018 Feb; 43():316-320. PubMed ID: 29020665
[TBL] [Abstract][Full Text] [Related]
6. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular Carcinoma.
Lorente L; Rodriguez ST; Sanz P; Abreu-González P; Díaz D; Moreno AM; Borja E; Martín MM; Jiménez A; Barrera MA
Int J Mol Sci; 2016 Apr; 17(4):500. PubMed ID: 27058525
[TBL] [Abstract][Full Text] [Related]
7. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation.
Zhang Q; Deng YL; Liu C; Huang LH; Shang L; Chen XG; Wang LT; Du JZ; Wang Y; Wang PX; Zhang H; Shen ZY
World J Gastroenterol; 2016 Nov; 22(43):9571-9585. PubMed ID: 27920478
[TBL] [Abstract][Full Text] [Related]
9. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina.
Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693
[TBL] [Abstract][Full Text] [Related]
10. How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.
Xiao GQ; Yan L; Yang J
Hepatogastroenterology; 2014 Oct; 61(135):2077-83. PubMed ID: 25713913
[TBL] [Abstract][Full Text] [Related]
11. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma.
Lorente L
World J Gastroenterol; 2018 Oct; 24(37):4230-4242. PubMed ID: 30310256
[TBL] [Abstract][Full Text] [Related]
12. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
14. Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
Kornberg A; Schernhammer M; Kornberg J; Friess H; Thrum K
Dig Dis Sci; 2019 Jan; 64(1):269-280. PubMed ID: 30259282
[TBL] [Abstract][Full Text] [Related]
15. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
[TBL] [Abstract][Full Text] [Related]
16. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
17. Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.
Bernardi N; Chedid MF; Grezzana-Filho TJM; Chedid AD; Pinto MA; Leipnitz I; Prediger JE; Prediger C; Backes AN; Hammes TO; Guerra LT; de Araujo A; Alvares-da-Silva MR; Kruel CRP
Dig Dis Sci; 2019 Jun; 64(6):1695-1704. PubMed ID: 30637547
[TBL] [Abstract][Full Text] [Related]
18. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Kang WH; Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
Liver Transpl; 2017 Jun; 23(6):781-790. PubMed ID: 28240808
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation.
Zhang W; Kim R; Quintini C; Hashimoto K; Fujiki M; Diago T; Eghtesad B; Miller C; Fung J; Tan A; Menon KV; Aucejo F
Liver Transpl; 2015 Jan; 21(1):101-11. PubMed ID: 25283528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
